FMR LLC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 111 filers reported holding FIBROGEN INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$277,535
-46.7%
321,631
+66.7%
0.00%
Q2 2023$520,914
-95.0%
192,931
-65.3%
0.00%
Q1 2023$10,362,458
+5560.7%
555,330
+4759.8%
0.00%
Q4 2022$183,061
-81.2%
11,427
-84.7%
0.00%
Q3 2022$973,000
+23.8%
74,812
+0.5%
0.00%
Q2 2022$786,000
-12.7%
74,414
-0.6%
0.00%
Q1 2022$900,000
+1775.0%
74,855
+2076.7%
0.00%
Q4 2021$48,000
-99.4%
3,439
-99.6%
0.00%
-100.0%
Q3 2021$7,957,000
-91.8%
778,622
-78.6%
0.00%
-87.5%
Q2 2021$96,734,000
-51.3%
3,632,508
-36.5%
0.01%
-52.9%
Q1 2021$198,512,000
-9.3%
5,719,181
-3.1%
0.02%
-10.5%
Q4 2020$218,893,000
-19.4%
5,901,659
-10.6%
0.02%
-29.6%
Q3 2020$271,552,000
+4.4%
6,603,886
+2.9%
0.03%
-6.9%
Q2 2020$260,170,000
-23.7%
6,419,221
-34.6%
0.03%
-38.3%
Q1 2020$340,878,000
-15.8%
9,809,447
+4.0%
0.05%
+4.4%
Q4 2019$404,632,000
+25.4%
9,434,188
+8.1%
0.04%
+15.4%
Q3 2019$322,743,000
-25.4%
8,727,485
-8.9%
0.04%
-23.5%
Q2 2019$432,727,000
-20.6%
9,577,841
-4.5%
0.05%
-21.5%
Q1 2019$545,118,000
+20.7%
10,029,786
+2.8%
0.06%
+4.8%
Q4 2018$451,702,000
-17.2%
9,760,216
+8.7%
0.06%
+1.6%
Q3 2018$545,610,000
-48.3%
8,981,236
-46.8%
0.06%
-50.0%
Q2 2018$1,055,959,000
+234.2%
16,868,347
+146.7%
0.12%
+221.1%
Q1 2018$315,951,000
-1.7%
6,838,779
+0.9%
0.04%0.0%
Q4 2017$321,337,000
-10.1%
6,779,259
+2.1%
0.04%
-11.6%
Q3 2017$357,316,000
+231.6%
6,641,560
+99.1%
0.04%
+230.8%
Q2 2017$107,753,000
+158.0%
3,335,997
+96.9%
0.01%
+160.0%
Q1 2017$41,771,000
+27.3%
1,694,574
+10.5%
0.01%
+25.0%
Q4 2016$32,815,000
+78.3%
1,533,431
+72.5%
0.00%
+100.0%
Q3 2016$18,401,000
+26.5%
888,903
+0.3%
0.00%0.0%
Q2 2016$14,548,000
-33.3%
886,503
-13.5%
0.00%
-33.3%
Q1 2016$21,820,000
-31.4%
1,024,903
-1.9%
0.00%
-25.0%
Q4 2015$31,826,000
+55.2%
1,044,503
+11.7%
0.00%
+33.3%
Q3 2015$20,506,000
+58.2%
935,503
+69.6%
0.00%
+50.0%
Q2 2015$12,963,000
-48.3%
551,603
-31.0%
0.00%
-33.3%
Q1 2015$25,077,000
-17.5%
799,142
-28.1%
0.00%
-25.0%
Q4 2014$30,393,0001,111,6640.00%
Other shareholders
FIBROGEN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 305,784$8,143,0008.63%
Vantage Consulting Group Inc 605,713$16,130,0002.81%
GREAT POINT PARTNERS LLC 500,000$13,315,0002.79%
HHLR ADVISORS, LTD. 3,955,787$105,343,0001.08%
Intercontinental Wealth Advisors, LLC 191,300$5,094,0001.01%
Ikarian Capital, LLC 250,000$6,657,0000.54%
BHK Investment Advisors, LLC 45,100$1,201,0000.49%
Ikarian Capital, LLC 193,800$5,161,0000.42%
Omega Fund Management, LLC 130,646$3,479,0000.39%
Rhenman & Partners Asset Management AB 200,000$5,326,0000.36%
View complete list of FIBROGEN INC shareholders